openPR Logo
Press release

What are the Growth Drivers of Breast Cancer Diagnostics Market Size? GE Healthcare, Phillips Healthcare, Hologic Inc., Fujifilm Holdings Corporation, Gamma Medica Inc., Toshiba Corporation, Dilion Technologies Inc., Genomic Health

04-29-2020 11:37 AM CET | Health & Medicine

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport.com
Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market

Global Breast Cancer Diagnostics Market is valued approximately USD 5.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020-2026. Breast cancer is a malignant tumor formed in the breast cells that can spread into the whole parts of the body. It is diagnosed with the use of several tests to locate the site of initiation and the spread of the tumor to several parts of the body.

Request a sample Report of Breast Cancer Diagnostics Market at: https://www.marketstudyreport.com/request-a-sample/2610785/?utm_source=OPR.com/&utm_medium=SP

At the initial stage, it can be diagnosed through certain screening tests such as yearly mammograms, MRI and CT scan. Increasing incidence of breast cancer among women, growing number of approvals for breast cancer diagnosis technologies, and favorable reimbursement framework for breast cancer diagnosis are the few factors responsible for high CAGR of the market over the forecast period.

According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common form of cancer in women worldwide with an average 2million new cases being detected every year. American Cancer Research Society (ACRS) anticipates by 2030, that incident rate of breast cancer is expected to reach over 9.9 million cases with over 5.5 million annual deaths, primarily due to aging population. Similarly, as per the European Breast Cancer Coalition, incidence in the EU-28 in 2018 was estimated to be around 404,920. This, in turn, is anticipated to accelerate the demand of breast cancer diagnostics around the world. However, high installation cost of devices and side effects of radiation are the few factors expected to impede the growth of the market over the forecast period of 2020-2026.

Major market player included in this report are:
o Hologic Inc.
o GE Healthcare
o Phillips Healthcare
o Fujifilm Holdings Corporation
o Gamma Medica Inc.
o Toshiba Corporation
o Aurora Imaging Technology Inc.
o Dilion Technologies Inc.
o Genomic Health
o NanoString Technologies, Inc.

The regional analysis of global Breast Cancer Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high patient awareness, well-established diagnostic infrastructure, and the early adoption of technologically advanced imaging systems in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising incidence of breast cancer and rapidly improving healthcare infrastructure in the countries like China and India.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Type:
o Ionizing breast imaging technologies
o Non-ionizing imaging technologies

By End-User:
o Hospitals
o Cancer research centers/institutes
o Diagnostic Clinical laboratories
o Ambulatory Surgical centers

By Region:
o North America
o U.S.
o Canada
o Europe
o UK
o Germany
o Asia Pacific
o China
o India
o Japan
o Latin America
o Brazil
o Mexico
o Rest of the World

Table of Contents:

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)
1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Diagnostics Market Dynamics
3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis

Chapter 5. Global Breast Cancer Diagnostics Market, by Diagnostic Type

Chapter 6. Global Breast Cancer Diagnostics Market, by End-User

Chapter 7. Global Breast Cancer Diagnostics Market, Regional Analysis

Chapter 8. Breast Cancer Diagnostics Market Competitive Intelligence

Ask for Discount on Breast Cancer Diagnostics Market Report at: https://www.marketstudyreport.com/check-for-discount/2610785/?utm_source=OPR.com/&utm_medium=SP

Related Reports: https://www.marketwatch.com/press-release/smart-hospitals-market-share-historical-growth-analysis-opportunities-and-forecast-to-2025-2020-04-27

Contact Us:
Market Study Report LLC,
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What are the Growth Drivers of Breast Cancer Diagnostics Market Size? GE Healthcare, Phillips Healthcare, Hologic Inc., Fujifilm Holdings Corporation, Gamma Medica Inc., Toshiba Corporation, Dilion Technologies Inc., Genomic Health here

News-ID: 2029137 • Views: 242

More Releases from marketstudyreport.com

Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Mesothelioma: The “Orphan” Cancer
Government funding remains elusive for deadly disease Newton, MA. Oct. 1st 2007. While Americans have long been romanced by campaigns for breast cancer and leukemia research, it may be some time before mesothelioma enjoys a stint in the spotlight. Despite the fact that over 2,500 cases of the disease are diagnosed in the U.S. each year—with as many or more dying from it—the need to develop effective treatments for mesothelioma victims